-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Initiates Coverage On Turn Therapeutics with Buy Rating, Announces Price Target of $8

Benzinga·12/29/2025 12:51:59
Listen to the news
D. Boral Capital analyst Jason Kolbert initiates coverage on Turn Therapeutics (NASDAQ:TTRX) with a Buy rating and announces Price Target of $8.